No Data
Cellectar Shares Fall as Updated Data For Investigational Radiotherapy Shows Drop in Major Response Rate
Crude Oil Down 2%; GE Aerospace Earnings Top Views
Cancer-Focused Cellectar Biosciences Stock Trades Lower Despite Meeting Goal In Blood Cancer Study
Cellectar Falls After Updating Pivotal Data for Lead Asset
Top Premarket Decliners
Express News | Cellectar Biosciences Shares Are Trading Lower. The Company Announced Results From Its CLOVER WaM Pivotal Study Evaluating Iopofosine I 131